Investment in pharma by WFS

Written by: Alwyn Brice |
Comment on this article

Worldwide Flight Services’ investment in 12 dedicated pharma facilities at airports in Europe, the US and Africa generated significant increases in time- and temperature-sensitive volumes during the first five months of 2020.

These will provide vital support to airlines, freight forwarders and their healthcare customers involved in the global distribution of a coronavirus vaccine once one becomes available.

The growth of pharma shipments by air in the past two to three years, and the development of premium products by airlines for temperature-controlled healthcare and life science shipments, prompted WFS to make a multi-million Euro investment in pharma centres at its airport stations in Amsterdam, Barcelona, Brussels, Cape Town, Copenhagen, Frankfurt, Johannesburg, London, Madrid, Miami, New York and Paris CDG. With the importance of health and well-being taking on even greater significance for consumers since the outbreak of COVID-19, shipment volumes and the number of airlines using the new WFS facilities have been rising month on month.

This material is protected by The Airports Publishing Network Ltd copyright see Terms and Conditions.
One-off usage is permitted but bulk copying is not. For multiple copies contact


Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code